No Picture
News

Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty

– Mean Pain Scores Remain in Mild Range for 72 Hours following Surgery — 75% of Patients Were Discharged without Opioids –

SAN DIEGO, Oct. 2, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focu… […]

No Picture
News

Global Genes Report Finds Technology Reshaping the Rare Disease Landscape, but Non-Scientific Challenges Threaten to Impede Progress

Report seeks to foster creative thinking and new approaches to addressing obstacles to patients getting the answers and care they need

ALISO VIEJO, Calif., Sept. 18, 2019 /PRNewswire/ — The rapid progress of technology is creating an opportunity to … […]

No Picture
News

NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice® System for Limb Lengthening

SAN DIEGO, Aug. 14, 2019 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a milestone of 10… […]

No Picture
News

TMRW Robotic Process Automation Platform Goes Live at San Diego Fertility Center, Vios Fertility Institute – Chicago and Reproductive Medicine Associates of New York

Multi-Site Study to Track Improvements to Safety and Results Achieved through Process Automation for the Preservation of Embryos and Other Fertility Cells

NEW YORK and CHICAGO and SAN DIEGO, July 16, 2019 /PRNewswire/ — TMRW, the creator of the firs… […]

No Picture
News

Thermo Fisher Scientific Launches Powerful Invitrogen iBright 1500 Imaging System Series for Western Blot and Gel Imaging

Featuring advanced time saving technology and intuitive user interface, designed to accelerate science

CARLSBAD, Calif., June 17, 2019 /PRNewswire/ — For biological researchers requiring high-quality images from their samples without over-investing … […]

No Picture
News

Calidi Biotherapeutics Announces A Collaborative Study With The National Institutes Of Health (NIH) On The Therapeutic Potential Of Oncolytic Viruses Delivered By Mesenchymal Stem Cells

SAN DIEGO, May 28, 2019 /PRNewswire/ — Calidi Biotherapeutics, Inc., a clinical?stage biotherapeutics company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced their ongoing scientific collaboration with David F…. […]